Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma
08/07/2021
/
Publications
/
Secondary cancer
This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...
Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016
08/02/2021
/
Publications
/
IMPT
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
01/10/2019
/
Publications
This study aimed to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT for prostate cancer patients. The data of...
Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.
11/12/2019
/
Publications
A 4-room center treating ~90 patients/day, treating for ~7 years underwent a software upgrade which reduced room and energy switching times from ~30 to~20 sec...
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
11/08/2019
/
Publications
/
Pencil Beam Scanning - PBS
Toxicity
This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...
MRI-based IMPT planning for prostate cancer.
11/11/2019
/
Publications
/
IMPT
Published in the Green Journal, this study led by MGH aimed to quantify the clinical applicability of converted MR images as a substitute of CT for IMPT...
Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.
11/08/2019
/
Publications
/
Hypofractionation
A cohort of 146 patients with low-risk prostate cancer were treated to 60 Gy (cobalt Gy equivalent) of proton therapy (20 fractions of 3.0 Gy per fraction) in 4...
A population-based assessment of proton beam therapy utilization in California.
01/02/2020
/
Publications
Based on data from California Cancer Registry, this study reported that of the 2,499,510 people with a cancer diagnosis during the study period, 578,632 (23%)...
Proton beam radiotherapy for anal and rectal cancers.
03/02/2020
/
Publications
/
Hypofractionation
A review article looked at the current status of PBT for anal and rectal cancers. PBT offers appealing potential to reduce toxicity, increase patient compliance...
Proton beam re-irradiation for gastrointestinal malignancies: a systematic review.
03/02/2020
/
Publications
/
Reirradiation
A systematic review assessing for reports of proton-beam reirradiation for recurrent or second primary GI cancers. 7 included studies reported on proton-beam re...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.